| Financial Year |
March 31 2023 |
| Monetary Funds |
2,226,451,814.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,855,187.32 |
| Accounts Receivable |
6,716,113,725.56 |
| Advances to Suppliers |
33,831,405.15 |
| Other Receivables |
66,613,346.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
47,808,198.07 |
| Inventories |
7,129,350.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
995,126,893.23 |
| Total Current Assets |
10,084,377,031.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,078,508,518.45 |
| Investment Properties |
733,547.32 |
| Fixed Assetes |
29,263,292,380.70 |
| Under-construction Projects |
3,180,365,474.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
366,205,092.87 |
| R&D expenses |
3,854,601.47 |
| Goodwill |
57,349,517.80 |
| Long-Term Deferred and Prepaid Expenses |
21,080,613.34 |
| Deferred Income Tax Assets |
106,190,198.66 |
| Other Non-Current Assets |
976,852,567.07 |
| Sub-Total of Non-Current Assets |
37,613,613,815.51 |
| Total Assets |
47,697,990,846.91 |
| Short-Term Loans |
2,244,807,605.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,653,427,384.35 |
| Accounts Received In Advance |
44,153,513.69 |
| Employee Compensation Payable |
38,151,814.28 |
| Taxes Payable |
232,458,214.06 |
| Interest Payable |
-- |
| Dividend Payable |
141,773,818.24 |
| Other payables |
634,362,551.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,329,500,396.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
8,176,861,479.42 |
| Long-term Loans |
21,515,919,657.69 |
| Bonds Payable |
298,695,152.14 |
| Long-Term Accounts Payable |
2,595,689,283.20 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
183,047,797.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,840,430,999.40 |
| Total Liabilities |
33,017,292,478.82 |
| Paid-In Capital(Or Share Stock) |
2,080,000,000.00 |
| Capital Surplus |
4,199,871,203.56 |
| Surplus Reserve |
139,446,089.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,327,114,352.79 |
| Minority Stockholder's Interest |
5,923,136,497.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,757,561,870.49 |
| Owner's Equity（Stockholder's Equity） |
14,680,698,368.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
47,697,990,846.91 |
